Introduction This audit of existing neuropharmacists shows how the role has grown over the years to help look after tasks suited to their skill set such as governance, introduction of new medication and path-way design, which has helped neurology teams in utilising the skills of each member of the team appropriately.

Aim To showcase the growing role of the neuropharmacist.

Methods A survey of existing neuropharmacists about their current roles and duties was undertaken, utilising the network of 50 neuropharmacists across the UK.

Results The role of the neuropharmacist has grown with subspecialism occurring in areas such as MS, headache, epilepsy and parkinsons disease. Patient facing clinics, leading on governance for the neu- roscience team, introduction of new medication to pathways and taking part in research across the healthcare economy (ie with primary care) are all areas that the neuropharmacist has been involved.

Conclusions The role of the neuropharmacist is diverse and can be utilised by the neurology team to ensure appropriate skill set are used to deliver the best care to patients. It is hope this work will help teams that do not have a neuropharmacist to develop business cases and redesign patient and disease pathways to include other members of the team.